CCI Photonics boosted by £100,000 support
A life sciences firm has received £100,000 backing.
CCI Photonics has been supported by LYVA Labs to develop a urinary tract infection test.
Bosses say the apparatus will carry out a 15-minute test before identifying the correct antibiotics for treatment.
They add current methods for testing bacteria causing urinary tract infections can take up to 72 hours.
Dr Carlos Meza, CCI Photonics chief executive, said: “LYVA Labs' investment will help speed up the process of bringing our device to market, strengthen our quality management system as we prepare for regulatory approval, and develop our route-to-market strategy.”
CCI Photonics recently moved to Sci-Tech Daresbury, and has partnered with the Liverpool School of Tropical Medicine to further validate its technology.
It is taking part in the LYVA Labs’ incubator programme.
Akshay Bhatnagar, LYVA Labs’ head of investments, added: “We are excited to support Carlos and the team to develop this game-changing technology with the potential to help urinary tract infection sufferers all over the world and combat the scourge of antimicrobial resistance.”
Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →
How businesses can reduce workplace safety risks with custom solutions
Tech firm unveils jobs plan after £530,000 backing
SMEs urged to think big at Newcastle event
B Corp is a commitment, not a one-time win
Government must get in gear on vehicle transition
A legacy in stone and spirit
Shaping the future: Your guide to planning reforms
The future direction of expert witness services
Getting people into gear for a workplace return
What to expect in the Spring Statement
Sunderland leading way in UK office supply market
Key construction developments in 2025